Home›Stock Screener›Acutaas Chemicals›Quarterly Results

Acutaas Chemicals Quarterly Results

Latest Quarter Net Profit
₹123 Cr
QSept 2026
Quarterly Results

Acutaas Chemicals quarterly results. In Sept 2026, Acutaas Chemicals (ACUTAAS) reported revenue ₹442 Cr and net profit ₹123 Cr — revenue +39.9% YoY. Also explore ACUTAAS price movement history to track price trends across different timeframes.

ACUTAAS Quarterly Results — Revenue, Profit & EPS Highlights

Acutaas Chemicals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View Acutaas Chemicals yearly highs lows for the annual high/low range and current price position.

  • Revenue of ₹442 Cr in Sept 2026 (-0.5% vs Mar 2026, +39.9% vs Sept 2025)
  • Net Profit of ₹123 Cr in Sept 2026 (-8.2% vs Mar 2026, +70.8% vs Sept 2025)
  • EBITDA of ₹181 Cr in Sept 2026 (-7.2% vs Mar 2026)
  • Operating Margin of 40.0% in Sept 2026 (-2.0pp vs Mar 2026)
  • Earnings Per Share of ₹15.29 in Sept 2026 (-5.0% vs Mar 2026)

Acutaas Chemicals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ACUTAAS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 442 444 332 316 314 -0.5% 39.9%
Net Profit (₹ Cr) 123 134 75 72 63 - -
EBITDA (₹ Cr) 181 195 115 105 91 - -
EPS (₹) 15.29 16.09 9.07 8.82 7.80 - -
Operating Margin (%) 40.0% 42.0% 34.0% 31.0% 28.0% - -

ACUTAAS Share Price Trend — 1-Year Movement Across Quarterly Results

Acutaas Chemicals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Acutaas Chemicals share price chart.

Profitability Ratios

Profit Margin 27.8%
EBITDA Margin 41.0%
Operating Margin 40.0%
ROE (Annual) 28.8%

Balance Sheet Highlights

Total Assets ₹1,984 Cr
Total Equity ₹1,711 Cr
Current Assets ₹ Cr
Current Liabilities ₹42 Cr

Cash Flow Analysis

Operating Cash Flow ₹292 Cr
Investing Cash Flow ₹-266 Cr
Financing Cash Flow ₹4 Cr
Net Cash Flow ₹30 Cr

Current Market Data

Current Price ₹3977.10
Exchange NSE
Last Updated Nov 19, 2026

ACUTAAS vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Acutaas Chemicals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores